Showing posts with label BioTech. Show all posts
Showing posts with label BioTech. Show all posts

Wednesday, August 3, 2022

Look Out for Life Sciences

After noticing a cup and handle formation in process, I initiated a position in Meridan Bioscience. The stock has since broken out and could have room to run. Let's learn more!



 

Monday, November 1, 2021

T-Cell Immunotherapy stock $PDSB primed to run?

In evaluating PDS Biotechnology, noting immunotherapy is considered as perhaps having the greatest area of potential for developing effective cancer drugs utilizing our own immune system, I found the company description really attractive. 

Is T-Cell immunotherapy stock $PDSB primed to run?


 

Sunday, August 29, 2021